Showing 371 results

Filters Content type: News, Editors' picks Topic: PrEP science

Research, news and information on the effectiveness of oral pre-exposure prophylaxis (PrEP) and its impact on HIV epidemics, as well as clinical issues for PrEP users.

PrEP

PrEP and the trans community webinar

News
10 December 2020
PrEP science

How the vaginal microbiome may affect HIV prevention

Editor's pick
EurekAlert
4 December 2020
HIV treatment

Top 10 HIV Clinical Developments of 2020

Editor's pick
TheBodyPro
1 December 2020
Injectable & long-acting PrEP

Study of injectable PrEP reports the best efficacy seen yet for any form of PrEP in women

News
13 November 2020
Injectable & long-acting PrEP

Trial results reveal that long-acting injectable cabotegravir as PrEP is highly effective in preventing HIV acquisition in women

Editor's pick
World Health Organization
10 November 2020
Pharmaceutical industry

GlaxoSmithKline's HIV PrEP challenge looms as ViiV's long-acting drug tops Gilead's Truvada in women

Editor's pick
FiercePharma
10 November 2020
Injectable & long-acting PrEP

ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women

Editor's pick
ViiV press release
9 November 2020
PrEP programmes & uptake

Shared Decision-Making Aids Choice of PrEP

Editor's pick
Medscape (requires free registration)
29 October 2020
PrEP

PrEP in Europe webinar

News
16 September 2020
PrEP science

Q&A: What clinicians should know about starting, stopping and restarting PrEP

Editor's pick
Healio
14 September 2020
PrEP science

Trans and cis women and men all have similar levels of PrEP drugs in blood, directly observed dosing study finds

News
7 September 2020
PrEP science

Two different cases of PrEP failure despite high adherence underline that such events are rare, but should not be ignored

News
4 September 2020
Mental & emotional health problems

Sexual compulsivity and harmful drug use decreased in men who started PrEP in Amsterdam

News
24 August 2020
Clinical trials

Designing a New Generation of HIV Prevention Efficacy Trials

Editor's pick
AVAC
23 August 2020
Transmission & prevention

Top 10 articles on HIV prevention from AIDS 2020

News
31 July 2020
Adherence

Novel Immunoassay Demonstrates Predictive Utility in PrEP Adherence, HIV Protection

Editor's pick
Infectious Disease Advisor
28 July 2020
PrEP science

An Advocates' Primer on Long-Acting Injectable Cabotegravir for PrEP

Editor's pick
AVAC
16 July 2020
Pharmaceutical industry

GSK's ViiV, touting superior long-acting data, can challenge Gilead in HIV prevention: analyst

Editor's pick
FiercePharma
13 July 2020
PrEP science

A second study finds introducing PrEP to Africa considerably reduces HIV infections in women

News
9 July 2020
PrEP policies & guidelines

On-demand PrEP is highly effective, but some may find it confusing

News
8 July 2020
Injectable & long-acting PrEP

Injectable PrEP offers superior efficacy to oral PrEP in clinical trial

News
7 July 2020
PrEP science

PrEP prevents an estimated three-quarters of HIV infections in people at risk in large African study

News
4 July 2020
Clinical trials

Malawian women keen to join HIV prevention trials during pregnancy

News
19 June 2020
PrEP science

The Dangers of Excluding Women From HIV Prevention Drug Tests

Editor's pick
WIRED
10 June 2020